Suzhou K-Hiragawa Electronic Technology Co Ltd
SSE:603052
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Suzhou K-Hiragawa Electronic Technology Co Ltd
SSE:603052
|
CN |
|
Sumitomo Pharma Co Ltd
TSE:4506
|
JP |
Balance Sheet
Balance Sheet Decomposition
Suzhou K-Hiragawa Electronic Technology Co Ltd
Suzhou K-Hiragawa Electronic Technology Co Ltd
Balance Sheet
Suzhou K-Hiragawa Electronic Technology Co Ltd
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
96
|
132
|
194
|
520
|
232
|
459
|
|
| Cash |
96
|
132
|
194
|
520
|
232
|
459
|
|
| Short-Term Investments |
0
|
0
|
0
|
188
|
583
|
113
|
|
| Total Receivables |
285
|
312
|
418
|
595
|
521
|
483
|
|
| Accounts Receivables |
216
|
254
|
324
|
368
|
421
|
365
|
|
| Other Receivables |
69
|
58
|
95
|
227
|
100
|
118
|
|
| Inventory |
30
|
36
|
55
|
46
|
38
|
54
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
1
|
6
|
|
| Total Current Assets |
411
|
479
|
668
|
1 350
|
1 374
|
1 115
|
|
| PP&E Net |
104
|
102
|
107
|
122
|
167
|
454
|
|
| PP&E Gross |
104
|
102
|
107
|
122
|
167
|
454
|
|
| Accumulated Depreciation |
32
|
41
|
53
|
61
|
73
|
82
|
|
| Intangible Assets |
13
|
13
|
13
|
12
|
22
|
55
|
|
| Long-Term Investments |
10
|
6
|
0
|
0
|
10
|
12
|
|
| Other Long-Term Assets |
6
|
4
|
8
|
9
|
9
|
13
|
|
| Total Assets |
544
N/A
|
604
+11%
|
796
+32%
|
1 493
+88%
|
1 583
+6%
|
1 649
+4%
|
|
| Liabilities | |||||||
| Accounts Payable |
134
|
155
|
191
|
382
|
410
|
480
|
|
| Accrued Liabilities |
11
|
11
|
14
|
14
|
15
|
16
|
|
| Short-Term Debt |
31
|
85
|
155
|
1
|
0
|
26
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
1
|
2
|
3
|
1
|
|
| Other Current Liabilities |
4
|
2
|
6
|
4
|
5
|
3
|
|
| Total Current Liabilities |
179
|
253
|
367
|
402
|
432
|
527
|
|
| Long-Term Debt |
0
|
0
|
1
|
2
|
0
|
1
|
|
| Deferred Income Tax |
0
|
0
|
0
|
1
|
1
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
1
|
5
|
|
| Other Liabilities |
94
|
3
|
2
|
1
|
1
|
10
|
|
| Total Liabilities |
273
N/A
|
256
-6%
|
369
+44%
|
405
+10%
|
435
+7%
|
532
+22%
|
|
| Equity | |||||||
| Common Stock |
51
|
52
|
52
|
69
|
96
|
135
|
|
| Retained Earnings |
123
|
190
|
268
|
401
|
462
|
480
|
|
| Additional Paid In Capital |
96
|
107
|
107
|
617
|
590
|
551
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
51
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
271
N/A
|
349
+29%
|
427
+22%
|
1 087
+155%
|
1 148
+6%
|
1 116
-3%
|
|
| Total Liabilities & Equity |
544
N/A
|
604
+11%
|
796
+32%
|
1 493
+88%
|
1 583
+6%
|
1 649
+4%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
189
|
189
|
189
|
189
|
189
|
186
|
|